Tolerability/safety of sunitinib (SU) on schedule 2/1 in combination with capecitabine (C) in patients (pts) with advanced solid tumors (STs): A phase I dose-finding study

被引：1
|
作者：
Chiorean, E. G.
Sweeney, C. J.
Verschraegen, C. F.
Lee, F. C.
Jones, S. F.
Rabinowitz, I.
Tye, L.
Bello, A.
Chao, R.
Burris, H. A., III
机构：
[1] Univ New Mexico, Albuquerque, NM 87131 USA
[2] Indiana Univ, Indianapolis, IN 46204 USA
[3] Sarah Cannon Res Inst, Nashville, TN USA
[4] Pfizer Global Res & Dev, La Jolla, CA USA
[5] Pfizer Inc, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.3562
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3562
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors
    Fornier, M. N.
    Rathkopf, D.
    Shah, M.
    Patil, S.
    O'Reilly, E.
    Tse, A. N.
    Hudis, C.
    Lefkowitz, R.
    Kelsen, D. P.
    Schwartz, G. K.
    CLINICAL CANCER RESEARCH, 2007, 13 (19) : 5841 - 5846
  • [42] Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
    Robert, Francisco
    Sandler, Alan
    Schiller, Joan H.
    Liu, Glenn
    Harper, Karen
    Verkh, Lev
    Huang, Xin
    Ilagan, Jennifer
    Tye, Lesley
    Chao, Richard
    Traynor, Anne M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 669 - 680
  • [43] Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
    Francisco Robert
    Alan Sandler
    Joan H. Schiller
    Glenn Liu
    Karen Harper
    Lev Verkh
    Xin Huang
    Jennifer Ilagan
    Lesley Tye
    Richard Chao
    Anne M. Traynor
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 669 - 680
  • [44] SUNITINIB (SU) WITH CISPLATIN (P) AND CAPECITABINE (X) OR OXALIPLATIN (O) AND X (XELOX) IN ADVANCED GASTRIC CANCER (GC) - A PHASE I, DOSE-FINDING STUDY
    Park, S. R.
    Lee, K.
    Oh, D.
    Park, Y. I.
    Roh, E.
    Khosravan, R.
    Lu, D. R.
    Tursi, J. M.
    Lechuga, M. J.
    Bang, Y.
    ANNALS OF ONCOLOGY, 2010, 21 : 254 - 255
  • [45] A Phase I study of sorafenib in combination with capecitabine in patients with advanced, solid tumors
    Awada, A.
    Gil, T.
    Burk, K.
    Vanhamme, J.
    Mancini, I.
    Besse, T.
    Brendel, E.
    Matthys, A.
    Piccart, M.
    Hendlisz, A.
    EJC SUPPLEMENTS, 2006, 4 (12): : 33 - 34
  • [46] A phase I study of the safety and pharmacokinetics of the combination of pertuzumab (rhuMab 2C4) and capecitabine in patients with advanced solid tumors
    Albanell, Joan
    Montagut, Clara
    Jones, Eileen T.
    Pronk, Linda
    Mellado, Begona
    Beech, Janette
    Gascon, Pere
    Zugmaier, Gerhard
    Brewster, Michael
    Saunders, Mark P.
    Valle, Juan W.
    CLINICAL CANCER RESEARCH, 2008, 14 (09) : 2726 - 2731
  • [47] A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumors
    Bhuvaneswari Ramaswamy
    Tanios Bekaii-Saab
    Larry J. Schaaf
    Gregory B. Lesinski
    David M. Lucas
    Donn C. Young
    Amy S. Ruppert
    John C. Byrd
    Kristy Culler
    Diedre Wilkins
    John J. Wright
    Michael R. Grever
    Charles L. Shapiro
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 151 - 158
  • [48] A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumors
    Ramaswamy, Bhuvaneswari
    Bekaii-Saab, Tanios
    Schaaf, Larry J.
    Lesinski, Gregory B.
    Lucas, David M.
    Young, Donn C.
    Ruppert, Amy S.
    Byrd, John C.
    Culler, Kristy
    Wilkins, Diedre
    Wright, John J.
    Grever, Michael R.
    Shapiro, Charles L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (01) : 151 - 158
  • [49] Clofarabine administration weekly to adult patients with advanced solid tumors in a phase I dose-finding study.
    Cunningham, CC
    Nemunaitis, J
    Senzer, N
    Vukelja, S
    Richards, D
    Vukovic, V
    Weitman, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 647S - 647S
  • [50] Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumors
    Patnaik, A
    Warner, E
    Michael, M
    Egorin, MJ
    Moore, MJ
    Siu, LL
    Fracasso, PM
    Rivkin, S
    Kerr, I
    Litchman, M
    Oza, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) : 3677 - 3689
12345